M
Menko-Jan de Boer
Researcher at Radboud University Nijmegen
Publications - 153
Citations - 9759
Menko-Jan de Boer is an academic researcher from Radboud University Nijmegen. The author has contributed to research in topics: Myocardial infarction & Percutaneous coronary intervention. The author has an hindex of 46, co-authored 153 publications receiving 9222 citations. Previous affiliations of Menko-Jan de Boer include Radboud University Nijmegen Medical Centre.
Papers
More filters
Journal ArticleDOI
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD).
Lars Rydén,Eberhard Standl,Malgorzata Bartnik,Greet Van den Berghe,John Betteridge,Menko-Jan de Boer,Francesco Cosentino,Bengt Jönsson,Markku Laakso,Klas Malmberg,Silvia G. Priori,Jan Östergren,Jaakko Tuomilehto,Inga Thrainsdottir,Ilse Vanhorebeek,Marco Stramba-Badiale,Peter Lindgren,Qing Qiao,Silvia G. Priori,Jean-Jacques Blanc,Andrzej Budaj,John Camm,Veronica Dean,Jaap W. Deckers,Kenneth Dickstein,John Lekakis,Keith McGregor,Marco Metra,João Morais,Ady Osterspey,Juan Tamargo,José Luis Zamorano,J.W. Deckers,Michel E. Bertrand,Bernard Charbonnel,Erland Erdmann,Ele Ferrannini,Allan Flyvbjerg,Helmut Gohlke,Jose Ramon Gonzalez Juanatey,Ian D. Graham,Pedro Filipe Monteiro,Klaus G. Parhofer,Kalevi Pyörälä,Itamar Raz,Guntram Schernthaner,Massimo Volpe,David Wood +47 more
TL;DR: Guidelines and Expert Consensus documents aim to present management and recommendations based on all of the relevant evidence on a particular subject in order to help physicians to select the best possible management strategies for the individual patient, suffering from a specific condition, taking into account not only the impact on outcome, but also the risk benefit ratio of a particular diagnostic or therapeutic procedure.
Journal ArticleDOI
Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction
TL;DR: The findings suggest that ECG patterns reflect the effectiveness of myocardial reperfusion, and patients for whom reperfusions therapy by primary angioplasty was successful and who had normalised ST segments had limited damage to the myocardium and an excellent outlook during follow-up.
Journal ArticleDOI
Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty.
Giuseppe De Luca,Harry Suryapranata,Felix Zijlstra,Arnoud W J van 't Hof,Jan C.A. Hoorntje,A T Marcel Gosselink,Jan Henk Dambrink,Menko-Jan de Boer +7 more
TL;DR: It is shown that, in patients with STEMI treated by primary angioplasty, symptom-onset-to-balloon time, but not door- to-balloons time, is related to mortality, particularly in non-low-risk patients and in the absence of preprocedural anterograde flow.
Journal ArticleDOI
Angiographic Assessment of Reperfusion in Acute Myocardial Infarction by Myocardial Blush Grade
José P.S. Henriques,Felix Zijlstra,Arnoud W J van 't Hof,Menko-Jan de Boer,Jan-Henk E. Dambrink,Marcel Gosselink,Jan C.A. Hoorntje,Harry Suryapranata +7 more
TL;DR: MBG is a strong angiographic predictor of mortality in patients with TIMI 3 flow after primary angioplasty and should include both TIMi 3 flow and MBG 2 or 3 in the definition of successful reperfusion.
Journal ArticleDOI
Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries.
Steen Dalby Kristensen,Kristina G. Laut,Jean Fajadet,Zuzana Kaifoszova,Petr Kala,Carlo Di Mario,William Wijns,Peter Clemmensen,Vaja Agladze,Loizos Antoniades,Khalid F. AlHabib,Menko-Jan de Boer,Marc J. Claeys,Dan Deleanu,Dariusz Dudek,Andrejs Erglis,Martine Gilard,Omer Goktekin,Giulio Guagliumi,Thorarinn Gudnason,Kim Wadt Hansen,Kurt Huber,Stefan James,Tomáš Janota,Siobhan Jennings,Olli A. Kajander,John Kanakakis,Kiril K. Karamfiloff,Sasko Kedev,Ran Kornowski,Peter Ludman,Béla Merkely,Davor Milicic,Davor Milicic,Ruslan Najafov,Francesca A. Nicolini,Marko Noc,Miodrag Ostojic,Hélder Pereira,Dragana Radovanovic,Manel Sabaté,Mohamed Sobhy,Maxim V. Sokolov,Martin Studencan,Ibrahim Terzic,S. Wahler,Petr Widimsky +46 more
TL;DR: Large variations in reperfusion treatment are still present across Europe, and countries in Eastern and Southern Europe reported that a substantial number of STEMI patients are not receiving any reperfusions therapy.